Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Report 2021

Publisher Name :
Date: 31-Mar-2021
No. of pages: 145
Inquire Before Buying

The global CRISPR and CRISPR-Associated (Cas) Genes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR and CRISPR-Associated (Cas) Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Genome Editing

- Genetic Engineering

- gRNA Database/Gene Librar

- CRISPR Plasmid

- Human Stem Cells

- Genetically Modified Organisms/Crops

- Cell Line Engineering

Segment by Application

- Biotechnology Companies

- Pharmaceutical Companies

- Academic Institutes

- Research and Development Institutes

The CRISPR and CRISPR-Associated (Cas) Genes market is analysed and market size information is provided by regions (countries). Segment by Application, the CRISPR and CRISPR-Associated (Cas) Genes market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Caribou Biosciences

- Addgene

- CRISPR THERAPEUTICS

- Merck KGaA

- Mirus Bio LLC

- Editas Medicine

- Takara Bio USA

- Thermo Fisher Scientific

- Horizon Discovery Group

- Intellia Therapeutics

- GE Healthcare Dharmacon

Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Report 2021

Table of Contents
1 CRISPR and CRISPR-Associated (Cas) Genes Market Overview
1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Scope
1.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016 & 2021 & 2027)
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts (2016-2027)
1.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size in Value Growth Rate (2016-2027)
1.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Trends (2016-2027)
2 CRISPR and CRISPR-Associated (Cas) Genes Estimates and Forecasts by Region
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
2.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2016-2021)
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.3 China CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.4 Japan CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.5 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.6 India CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
3 Global CRISPR and CRISPR-Associated (Cas) Genes Competition Landscape by Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Sales (2016-2021)
3.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2016-2021)
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020)
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Average Price by Company (2016-2021)
3.5 Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Review by Type (2016-2021)
4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
4.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2016-2021)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Type (2022-2027)
4.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2022-2027)
4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2022-2027)
5 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Review by Application (2016-2021)
5.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2021)
5.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application (2016-2021)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Application (2022-2027)
5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2022-2027)
5.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Application (2022-2027)
6 North America CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
6.1.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2016-2021)
6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2022-2027)
7 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
8.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
8.1.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
8.1.2 China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
8.2 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
8.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
8.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
8.3 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
9.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
9.1.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
9.1.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
9.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
9.2.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
9.2.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
9.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
10.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
10.1.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
10.1.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
10.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
10.2.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
11.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
11.1.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
11.1.2 India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
11.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
11.2.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
11.2.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
11.3 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
11.3.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2016-2021)
11.3.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in CRISPR and CRISPR-Associated (Cas) Genes Business
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences Corporation Information
12.1.2 Caribou Biosciences Business Overview
12.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.1.5 Caribou Biosciences Recent Development
12.2 Addgene
12.2.1 Addgene Corporation Information
12.2.2 Addgene Business Overview
12.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Addgene CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.2.5 Addgene Recent Development
12.3 CRISPR THERAPEUTICS
12.3.1 CRISPR THERAPEUTICS Corporation Information
12.3.2 CRISPR THERAPEUTICS Business Overview
12.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.3.5 CRISPR THERAPEUTICS Recent Development
12.4 Merck KGaA
12.4.1 Merck KGaA Corporation Information
12.4.2 Merck KGaA Business Overview
12.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.4.5 Merck KGaA Recent Development
12.5 Mirus Bio LLC
12.5.1 Mirus Bio LLC Corporation Information
12.5.2 Mirus Bio LLC Business Overview
12.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.5.5 Mirus Bio LLC Recent Development
12.6 Editas Medicine
12.6.1 Editas Medicine Corporation Information
12.6.2 Editas Medicine Business Overview
12.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.6.5 Editas Medicine Recent Development
12.7 Takara Bio USA
12.7.1 Takara Bio USA Corporation Information
12.7.2 Takara Bio USA Business Overview
12.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.7.5 Takara Bio USA Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Corporation Information
12.8.2 Thermo Fisher Scientific Business Overview
12.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Corporation Information
12.9.2 Horizon Discovery Group Business Overview
12.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.9.5 Horizon Discovery Group Recent Development
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics Corporation Information
12.10.2 Intellia Therapeutics Business Overview
12.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.10.5 Intellia Therapeutics Recent Development
12.11 GE Healthcare Dharmacon
12.11.1 GE Healthcare Dharmacon Corporation Information
12.11.2 GE Healthcare Dharmacon Business Overview
12.11.3 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.11.5 GE Healthcare Dharmacon Recent Development
13 CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
13.1 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CRISPR and CRISPR-Associated (Cas) Genes
13.4 CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors List
14.3 CRISPR and CRISPR-Associated (Cas) Genes Customers
15 Market Dynamics
15.1 CRISPR and CRISPR-Associated (Cas) Genes Market Trends
15.2 CRISPR and CRISPR-Associated (Cas) Genes Drivers
15.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
15.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Region (2016-2021)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Region (2016-2021)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Region (2022-2027)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2022-2027)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) of Key Companies (2016-2021)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Company (2016-2021)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) by Company (2016-2021)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Company (2016-2021)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Sites and Area Served
Table 19. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2016-2021)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Type (2016-2021)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2016-2021)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Type (2022-2027)
Table 26. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Type (2022-2027)
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2022-2027)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2016-2021)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Application (2016-2021)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Application (2016-2021)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2022-2027)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Application (2022-2027)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2022-2027)
Table 37. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Application (2022-2027)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 42. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 43. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 44. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 45. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 46. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 47. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 48. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 49. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 50. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 51. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 52. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 54. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 55. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 56. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 57. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 58. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 59. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 60. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 61. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 62. China CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 63. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 64. China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 65. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 66. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 67. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 68. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 69. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 70. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 71. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 72. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 73. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 74. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 75. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 76. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 78. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 79. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 80. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 81. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 82. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 83. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 84. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 85. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 98. India CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 99. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 100. India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 101. India CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 102. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 103. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 104. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 105. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 106. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 107. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 108. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 109. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 110. Caribou Biosciences Corporation Information
Table 111. Caribou Biosciences Description and Business Overview
Table 112. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Caribou Biosciences Recent Development
Table 115. Addgene Corporation Information
Table 116. Addgene Description and Business Overview
Table 117. Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Addgene CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. Addgene Recent Development
Table 120. CRISPR THERAPEUTICS Corporation Information
Table 121. CRISPR THERAPEUTICS Description and Business Overview
Table 122. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. CRISPR THERAPEUTICS Recent Development
Table 125. Merck KGaA Corporation Information
Table 126. Merck KGaA Description and Business Overview
Table 127. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product
Table 129. Merck KGaA Recent Development
Table 130. Mirus Bio LLC Corporation Information
Table 131. Mirus Bio LLC Description and Business Overview
Table 132. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product
Table 134. Mirus Bio LLC Recent Development
Table 135. Editas Medicine Corporation Information
Table 136. Editas Medicine Description and Business Overview
Table 137. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 139. Editas Medicine Recent Development
Table 140. Takara Bio USA Corporation Information
Table 141. Takara Bio USA Description and Business Overview
Table 142. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product
Table 144. Takara Bio USA Recent Development
Table 145. Thermo Fisher Scientific Corporation Information
Table 146. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Thermo Fisher Scientific Description and Business Overview
Table 148. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 149. Thermo Fisher Scientific Recent Development
Table 150. Horizon Discovery Group Corporation Information
Table 151. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Horizon Discovery Group Description and Business Overview
Table 153. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product
Table 154. Horizon Discovery Group Recent Development
Table 155. Intellia Therapeutics Corporation Information
Table 156. Intellia Therapeutics Description and Business Overview
Table 157. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 159. Intellia Therapeutics Recent Development
Table 160. GE Healthcare Dharmacon Corporation Information
Table 161. GE Healthcare Dharmacon Description and Business Overview
Table 162. GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. GE Healthcare Dharmacon CRISPR and CRISPR-Associat
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs